Publications

Publications 2007

GLOBAL PROFILING OF EGFR GENE MUTATION, AMPLIFICATION, REGULATION AND TISSUE PROTEIN EXPRESSION IN UNKNOWN PRIMARY CARCINOMAS: TO TARGET OR NOT TO TARGET?
L. Dova, G. Pentheroudakis, I. Georgiou, V. Malamou-Mitsi, G. Vartholomatos, G. Fountzilas, N. Kolaitis, E. Kitsiou, N. Pavlidis
Clin Exp Metastasis. 2007;24(2):79-86 (Epub 2007 Mar 28)


REIRADIATION FOR RECURRENT NECK METASTASES OF HEAD AND NECK TUMORS USING CT GUIDED INTERSTITIAL 192Ir HDR BRACHYTHERAPY
C. Kolotas, N. Tselis, M. Sommerland, S. Roddiger, T. Schnabel, D. Baltas, A. Kalogera-Fountzila, G. Fountzilas, N. Zamboglou
Strahlentherapie Onkol. 2007 Feb;183(2):69-75


WEEKDAY ON-WEEKEND OFF ORAL CAPECITABINE: A PHASE I STUDY OF A CONTINUOUS SCHEDULE BETTER SIMULATING PROTRACTED FLUOROPYRIMIDINE THERAPY
G. Pentheroudakis, P. Pappas, V. Golfinopoulos, G. Fountzilas, M. Nikolaidou, V.A. Boumba, T. Vougiouklakis, L. Nikiforidis, E. Tzamakou, O. Siarabi, M. Marselos, N. Pavlidis
Cancer Chemotherapy Pharmacol. 2007 Oct;60(5):733-9 (Epub 2007 Feb 28)


NOVEL GENOMIC REARRANGEMENTS IN THE BRCA1 GENE DETECTED IN GREEK BREAST/OVARIAN CANCER PATIENTS
S. Armaou, I. Konstantopoulou, T. Anagnostopoulos, E. Razis, I. Boukovinas, N. Xenidis, G. Fountzilas, D. Yannoukakos
European J Cancer. 2007 Jan;43(2):443-53 (Epub 2006 Dec 14)


MOLECULAR MARKERS IN EXTRANODAL GERM CELL TUMORS: A MATCHED CASE-CONTROL STUDY
D. Pectasides, C. Valavanis, M. Nikolaou, G. Aravantinos, I. Lekka, D. Skarlos, Ch. Kalofonos, G. Fountzilas, V. Kostopoulou, A. Zizi, T. Economopoulos, P. Arapantoni-Datioti
Histopathology 2007 Feb;50(3):394-6


PROGNOSTIC SIGNIFICANCE OF HER-2, p53 and Bcl-2 IN PATIENTS WITH EPITHELIAL OVARIAN CANCER
V. Malamou-Mitsi, O. Crikoni, E. Timotheadou, G. Aravantinos, E. Vrettou, N. Agnantis, G. Fountzilas
Anticancer Res. 2007 Mar-Apr;27(2):1157-65


KIT EXPRESSION IN MALE GERM CELL TUMORS
M. Nikolaou, C. Valavanis, G. Aravantinos, G. Fountzilas, N. Tamvakis, I. Lekka, P. Arapantoni-Dadioti, A. Zizi, Th. Economopoulos, D. Pectasides

Anticancer Res. 2007 May-Jun;27(3B):1685-8


INTRATUMORAL CRH MODULATES IMMUNO-ESCAPE OF OVARIAN CANCER CELLS THROUGH FasL REGULATION
V. Minas, A. Rolaki, S.N. Kalantaridou, J. Sidiropoulos, S. Mitrou, G. Petsas, U. Jeschke, E.A. Paraskevaidis, G. Fountzilas, G.P. Chrousos, N. Pavlidis, A. Makrigiannakis
Br J Cancer 2007 Sep 3;97(5):637-45 (Epub 2007 Jul 31)


EXPRESSION OF A MOLECULAR MARKER PANEL AS A PROGNOSTIC TOOL IN GASTRIC CANCER PATIENTS TREATED POSTOPERATIVELY WITH DOCETAXEL AND IRINOTECAN. A STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
D.V. Skarlos, M. Bai, A. Goussia, E. Samantas, E. Galani, D. Tsavdaridis, M. Karina, P. Papakostas, A. Konstantara, G. Fountzilas
Anticancer Res. 2007 Jul-Aug;27(4C):2973-83


COMBINATION CHEMOTHERAPY WITH CISPLATIN, ETOPOSIDE AND IRINOTECAN IN PATIENTS WITH EXTENSIVE SMALL-CELL LUNG CANCER: A PHASE II STUDY OF THE HELLENIC CO-OPERATIVE ONCOLOGY GROUP
D. Pectasides, E. Samantas, G. Fountzilas, E. Briasoulis, P. Kosmidis, D. Skarlos, M.A. Dimopoulos, H.P. Kalofonos, T. Economopoulos, K. Syrigos
Lung Cancer 2007 Dec;58(3):355-61 (Epub 2007 Aug 15)


INTENSIVE WEEKLY CHEMOTHERAPY WITH DOCETAXEL, EPIRUBICIN AND CARBOPLATIN WITH G-CSF SUPPORT IN PATIENTS WITH ADVANCED GASTRIC CANCER: A HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG) PHASE II STUDY
T. Makatsoris, P. Papakostas, H.P. Kalofonos, I. Xanthakis, D. Tsavdaridis, G. Aravantinos, H. Gogas, G. Klouvas, P. Kosmidis, D. Pectasides, G. Fountzilas
Med Oncol. 2007;24(3):301-7


CT-GUIDED INTERSTITIAL HDR BRACHYTHERAPY FOR RECURRENT GLIOBLASTOMA MULTIFORME: LONG-TERM RESULTS
N. Tselis, C. Kolotas, G. Birn, S. Roddiger, I. Filipowicz, M. Kontova, G. Fountzilas, P. Selviaridis, D. Baltas, G. Anagnostopoulos, N. Zamboglou

Strahlentherapie Onkol. 2007 Oct;183(10):563-70


CEOP-21 VERSUS CEOP-14 CHEMOTHERAPY WITH OR WITHOUT RITUXIMAB FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH AGRESSIVE LYMPHOMAS: RESULTS OF THE HE22A99 TRIAL OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
T. Economopoulos, A. Psyrri, M.A. Dimopoulos, A. Kalogera-Fountzila, N. Pavlidis, C. Tsatalas, C. Nikolaides, S. Mellou, N. Xiros, G. Fountzilas
Cancer J. 2007 Sep-Oct;13(5):327-34


COMPARISON OF HER2 DETECTION METHODS BETWEEN CENTRAL AND REGIONAL LABORATORIES IN GREECE
S. Papadopoulos, G. Kouvatseas, D. Skarlos, N. Malamos, E. Delliou, I. Saratsiotou, A. Ardavanis, D. Mavroudis, E. Skarpidi, P. Arapantoni, I. Karyda, F. Patakioyta, G. Aravantinos, E. Razis, G. Fountzilas, P. Kosmidis
Clin Breast Cancer. 2007 Oct;7(10):784-90


MITOXANTRONE PLUS VINORELBINE IN PRETREATED PATIENTS WITH METASTATIC BREAST CANCER
A. Onyenadum, H. Gogas, C. Markopoulos, D. Bafaloukos, G. Aravantinos, M. Mantzourani, A. Koutras, E. Tzorakoelefterakis, N. Xiros, T. Makatsoris, G. Fountzilas, H.P. Kalofonos
J Chemother. 2007 Oct;19(5):582-9


GEMCITABINE VERSUS GEMCITABINE-CARBOPLATIN FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2: A PROSPECTIVE RANDOMIZED PHASE II STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
P.A. Kosmidis, M.A. Dimopoulos, K. Syrigos, C. Nicolaides, G. Aravantinos, I. Boukovinas, D. Pectasides, G. Fountzilas, D. Bafaloukos, C. Bacoyiannis, H.P. Kalofonos
J Thorac Oncol. 2007 Feb;2(2):135-40


EVALUATION OF THE PROGNOSTIC ROLE OF A PANEL OF BIOMARKERS IN STAGE IB-IIA NON-SMALL CELL LUNG CANCER PATIENTS
E. Timotheadou, D.V. Skarlos, E. Samantas, S. Papadopoulos, S. Murray, J. Skrickova, C. Christodoulou, C. Papakostantinou, D. Pectasides, P. Papakostas, J. Kaplanova, E. Vrettou, M. Karina, P. Kosmidis, G.Fountzilas
Anticancer Res. 2007 Nov-Dec;27(6C):4481-9


EVALUATION OF THE PROGNOSTIC AND PREDICTIVE VALUE OF HER-1/EGFR IN BREAST CANCER PATIENTS PARTICIPATING IN A RANDOMIZED STUDY WITH DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY
O. Tzaida, H. Gogas, U. Dafni, A. Kyroydi, I. Papaspyrou, V. Kyriakou, V. Malamou-Mitsi, M. Alamani, C. Skopa, I. Kostopoulos, E. Kastritis, D. Pectasides, E. Briasoulis, H. Kalofonos, G. Aravantinos, G. Foutzilas, P. Arapantoni-Dadioti
Oncology. 2007;72(5-6):388-96 (Epub 2008 Jan 14)


MERKEL CELL CARCINOMA OF THE SKIN: A RESTROSPECTIVE STUDY OF 24 CASES BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)
D. Pectasides, G. Papaxoinis, E. Pectasides, H. Galani, E. Razi, N. Katodrytis, G. Fountzilas, T. Economopoulos
Oncology. 2007;72(3-4):211-8. Epub 2008 Jan 7


TWO CYCLES OF ETOPOSIDE/CISPLATIN CURED ALL PATIENTS WITH STAGR I TESTICULAR SEMINOMA: A RISK ADAPTED PROTOCOL OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP
A. Bamias, G. Aravantinos, C. Deliveliotis, A. Thanos, G. Klouvas, N. Antoniou, I. Poulias, T. Makatsoris, E. Samantas, M.A. Dimopoulos
Urology. 2007 Dec;70(6):1179-83


EPITHELIAL OVARIAN CARCINOMA IN YOUNGER VS OLDER WOMEN: IS AGE AN INDEPENDENT PROGNOSTIC FACTOR? THE HELLENIC COOPERATIVE ONCOLOGY GROUP EXPERIENCE
D. Pectasides, G. Fountzilas, G. Aravantinos, A. Bamias, H.P. Kalofonos, D. Skarlos, E. Briasoulis, A. Konstantara, T. Economopoulos, M.A. Dimopoulos
Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1003-10 (Epub 2007 Mar 15)


A RANDOMIZED TRIAL TO COMPARE THE EFFICACY AND SAFETY OF ANTIEMETIC TREATMENT WITH ONDASETRON AND ONDASETRON ZYDIS IN PATIENTS WITH BREAST CANCER TREATED WITH HIGH-DOSE EPIRUBICIN
D. Pectasides, U. Dafni, G. Aravantinos, E. Timotheadou, D.V. Skarlos, N. Pavlidis, A. Gaglia, H.P. Kalofonos, G. Fountzilas
Anticancer Res 2007 Nov-Dec;27(6C):4411-7


SYSTEMIC THERAPY IN METASTATIC OR RECURRENT ENDOMETRIALCANCER
D. Pectasides, E. Pectasides, T. Economopoulos
Cancer Treat Rev. 2007 Apr;33(2):177-90 (Epub 2006 Dec 29)